1. Home
  2. PCSA vs BOXL Comparison

PCSA vs BOXL Comparison

Compare PCSA & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCSA
  • BOXL
  • Stock Information
  • Founded
  • PCSA 2011
  • BOXL 1985
  • Country
  • PCSA United States
  • BOXL United States
  • Employees
  • PCSA N/A
  • BOXL N/A
  • Industry
  • PCSA Biotechnology: Pharmaceutical Preparations
  • BOXL Telecommunications Equipment
  • Sector
  • PCSA Health Care
  • BOXL Telecommunications
  • Exchange
  • PCSA Nasdaq
  • BOXL Nasdaq
  • Market Cap
  • PCSA 3.3M
  • BOXL 3.9M
  • IPO Year
  • PCSA N/A
  • BOXL 2017
  • Fundamental
  • Price
  • PCSA $0.20
  • BOXL $1.99
  • Analyst Decision
  • PCSA Strong Buy
  • BOXL Buy
  • Analyst Count
  • PCSA 1
  • BOXL 3
  • Target Price
  • PCSA $2.00
  • BOXL $5.00
  • AVG Volume (30 Days)
  • PCSA 44.0M
  • BOXL 18.5K
  • Earning Date
  • PCSA 08-12-2025
  • BOXL 08-06-2025
  • Dividend Yield
  • PCSA N/A
  • BOXL N/A
  • EPS Growth
  • PCSA N/A
  • BOXL N/A
  • EPS
  • PCSA N/A
  • BOXL N/A
  • Revenue
  • PCSA N/A
  • BOXL $121,223,000.00
  • Revenue This Year
  • PCSA N/A
  • BOXL N/A
  • Revenue Next Year
  • PCSA N/A
  • BOXL N/A
  • P/E Ratio
  • PCSA N/A
  • BOXL N/A
  • Revenue Growth
  • PCSA N/A
  • BOXL N/A
  • 52 Week Low
  • PCSA $0.15
  • BOXL $1.06
  • 52 Week High
  • PCSA $3.10
  • BOXL $10.65
  • Technical
  • Relative Strength Index (RSI)
  • PCSA 40.42
  • BOXL 62.35
  • Support Level
  • PCSA $0.19
  • BOXL $1.72
  • Resistance Level
  • PCSA $0.33
  • BOXL $1.89
  • Average True Range (ATR)
  • PCSA 0.07
  • BOXL 0.12
  • MACD
  • PCSA -0.01
  • BOXL 0.01
  • Stochastic Oscillator
  • PCSA 1.67
  • BOXL 95.12

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions including flat panels, LED video walls, and digital signage. The company also distributes science, technology, engineering, and math (or STEM) products, including 3D printing and robotics solutions and a portable science lab.

Share on Social Networks: